Literature DB >> 15348612

In vivo response of strontium and zinc-based ionomeric cement implants in bone.

K K Johal1, G Mendoza-Suárez, J I Escalante-García, R G Hill, I M Brook.   

Abstract

In this study the osteoconductive properties of strontium based ionomeric cements (ICs) named, LG125 and LG119, as well as zinc-based ICs, designated by LG130 and LG132, were compared. Wet ICs were surgically implanted into the femora of weaned Wistar rats for 4 weeks. To assess the percentage osseointegration the perimeter of the implant and the perimeter of bone in contact with the implant were measured using a pointer (the length of bone/implant interfacial contact). Osteoconduction was determined by taking six points at random around the perimeter of each ionomeric rod measuring the thickness of newly formed bone. The degree of osteoconduction was taken as the average thickness of new bone produced on the implant surface. It was found that osteoconduction was greatest in the strontium based IC implant LG125. From these studies it can be concluded that the composition LG125 might provide a useful purpose as a bone cement.

Entities:  

Year:  2002        PMID: 15348612     DOI: 10.1023/a:1014336517741

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  17 in total

1.  Ionomeric bone cement in neuro-otological surgery.

Authors:  R T Ramsden; R C Herdman; R H Lye
Journal:  J Laryngol Otol       Date:  1992-11       Impact factor: 1.469

2.  Potent effect of zinc acexamate on bone components in the femoral-metaphyseal tissues of elderly female rats.

Authors:  M Yamaguchi; Y H Gao
Journal:  Gen Pharmacol       Date:  1998-03

3.  Strontium inhibition of vitamin D3-induced calcium-binding protein (CaBP) and calcium absorption in chick intestine.

Authors:  R A Corradino; R H Wasserman
Journal:  Proc Soc Exp Biol Med       Date:  1970-03

4.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

Authors:  B L Riggs; S F Hodgson; W M O'Fallon; E Y Chao; H W Wahner; J M Muhs; S L Cedel; L J Melton
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

5.  Zinc is a potent inhibitor of osteoclastic bone resorption in vitro.

Authors:  B S Moonga; D W Dempster
Journal:  J Bone Miner Res       Date:  1995-03       Impact factor: 6.741

6.  A comparison of the effects of strontium chloride and calcium chloride on alveolar bone.

Authors:  E F Ferraro; R Carr; K Zimmerman
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

7.  Skeletal effects of zinc deficiency in growing rats.

Authors:  J Eberle; S Schmidmayer; R G Erben; M Stangassinger; H P Roth
Journal:  J Trace Elem Med Biol       Date:  1999-07       Impact factor: 3.849

8.  Acute zinc deficiency and trabecular bone loss in rats with talc granulomatosis.

Authors:  A Marusić; K Kos; A Stavljenić; S Vukicević
Journal:  Biol Trace Elem Res       Date:  1991-05       Impact factor: 3.738

9.  Stimulatory effect of zinc on bone formation in tissue culture.

Authors:  M Yamaguchi; H Oishi; Y Suketa
Journal:  Biochem Pharmacol       Date:  1987-11-15       Impact factor: 5.858

10.  Effects of strontium on calcium metabolism in rats. II. Strontium prevents the increased rate of bone turnover in ovariectomized rats.

Authors:  T Morohashi; T Sano; K Harai; S Yamada
Journal:  Jpn J Pharmacol       Date:  1995-06
View more
  11 in total

1.  Crystallization modifies osteoconductivity in an apatite-mullite glass-ceramic.

Authors:  C O Freeman; I M Brook; A Johnson; P V Hatton; R G Hill; K T Stanton
Journal:  J Mater Sci Mater Med       Date:  2003-11       Impact factor: 3.896

2.  Effects of strontium ranelate treatment on osteoblasts cultivated onto scaffolds of trabeculae bovine bone.

Authors:  Gerluza Aparecida Borges Silva; Bruno Machado Bertassoli; Cristiane Aparecida Sousa; Juliano Douglas Albergaria; Rayan Silva de Paula; Erika Cristina Jorge
Journal:  J Bone Miner Metab       Date:  2017-03-20       Impact factor: 2.626

3.  The optimum zinc content in set calcium phosphate cement for promoting bone formation in vivo.

Authors:  Xia Li; Yu Sogo; Atsuo Ito; Hirotaka Mutsuzaki; Naoyuki Ochiai; Takayuki Kobayashi; Satoshi Nakamura; Kimihiro Yamashita; Racquel Z Legeros
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2009-04-30       Impact factor: 7.328

4.  The role of Sr2+ on the structure and reactivity of SrO-CaO-ZnO-SiO2 ionomer glasses.

Authors:  Daniel Boyd; Mark R Towler; Sally Watts; Robert G Hill; Anthony W Wren; Owen M Clarkin
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

5.  Effect of strontium-containing hydroxyapatite bone cement on bone remodeling following hip replacement.

Authors:  Guo X Ni; Jian H Lin; Peter K Y Chiu; Zhao Y Li; William W Lu
Journal:  J Mater Sci Mater Med       Date:  2010-01       Impact factor: 3.896

6.  Strontium ions substitution in brushite crystals: the role of strontium chloride.

Authors:  Mohammad H Alkhraisat; Carmen Rueda; Enrique López Cabarcos
Journal:  J Funct Biomater       Date:  2011-05-31

7.  Biomimetic mineralized strontium-doped hydroxyapatite on porous poly(l-lactic acid) scaffolds for bone defect repair.

Authors:  Min Ge; Kun Ge; Fei Gao; Weixiao Yan; Huifang Liu; Li Xue; Yi Jin; Haiyun Ma; Jinchao Zhang
Journal:  Int J Nanomedicine       Date:  2018-03-20

8.  The Feasibility and Functional Performance of Ternary Borate-Filled Hydrophilic Bone Cements: Targeting Therapeutic Release Thresholds for Strontium.

Authors:  Kathleen MacDonald; Richard B Price; Daniel Boyd
Journal:  J Funct Biomater       Date:  2017-07-14

9.  Porous allograft bone scaffolds: doping with strontium.

Authors:  Yantao Zhao; Dagang Guo; Shuxun Hou; Hongbin Zhong; Jun Yan; Chunli Zhang; Ying Zhou
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

10.  Development of Zinc-Doped Hydroxyapatite by Sol-Gel Method for Medical Applications.

Authors:  Catalin Constantin Negrila; Mihai Valentin Predoi; Simona Liliana Iconaru; Daniela Predoi
Journal:  Molecules       Date:  2018-11-15       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.